Back

Can anti-hypertensive thiazide diuretics also reduce fragility fracture risk?

31 August 2019 (09:36 - 09:54)
Organised by:
Congress Presentation Part of: Drug treatment in hypertension - New insights Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Jose Pedro Sousa

Porto (Portugal)

3 More presentations in this session

Presentation thumbnail
State of the Art - Drug treatment in hypertension: unmet needs
Professor B. Williams (London, GB)
Slides Video
Presentation thumbnail
Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension
Ms P. Danaietash (Allschwil, CH)
Abstract Slides Video
Presentation thumbnail
New targets for blood pressure lowering drugs
Professor G. Parati (Milan, IT)

Access the full session

Session thumbnail
Drug treatment in hypertension - New insights

The Event

Event poster

ESC Congress 2019

31 August 2019 09:36 CET
You may be interested in
thumbnail
Congress Presentation
Impact of frailty on antihypertensive treatment in older adults
1 September 2025
thumbnail
Congress Presentation
Thiazides and skin cancer risk: should we be worried?
1 September 2019
thumbnail
Congress Presentation
Lower risks of sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset hip fracture risks in patients with type-2 diabetes: A propensity sc
28 August 2023
thumbnail
Congress Presentation
Role of urinary potassium to creatinine ratio for tailoring the type of diuretic regimen in patients with acute heart failure and diuretic resistance
23 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources